Anti-diabetogenic effect of the human amylin analogue, pramlintide, in Type 1 diabetes is not mediated by GLP-1.
(2002) In Diabetic Medicine 19(9). p.790-792
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/110402
- author
- Ahrén, Bo LU ; Adner, N ; Svartberg, J ; Petrella, E ; Holst, J J and Gutniak, M K
- organization
- publishing date
- 2002
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Diabetic Medicine
- volume
- 19
- issue
- 9
- pages
- 790 - 792
- publisher
- Wiley-Blackwell
- external identifiers
-
- pmid:12207819
- wos:000177774900015
- scopus:0036053256
- ISSN
- 1464-5491
- DOI
- 10.1046/j.1464-5491.2002.00657_1.x
- language
- English
- LU publication?
- yes
- id
- ee80cb2b-17db-4c91-8957-3eadfd700a7f (old id 110402)
- alternative location
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12207819&dopt=Abstract
- date added to LUP
- 2016-04-01 16:56:20
- date last changed
- 2024-01-26 15:22:30
@article{ee80cb2b-17db-4c91-8957-3eadfd700a7f,
author = {{Ahrén, Bo and Adner, N and Svartberg, J and Petrella, E and Holst, J J and Gutniak, M K}},
issn = {{1464-5491}},
language = {{eng}},
number = {{9}},
pages = {{790--792}},
publisher = {{Wiley-Blackwell}},
series = {{Diabetic Medicine}},
title = {{Anti-diabetogenic effect of the human amylin analogue, pramlintide, in Type 1 diabetes is not mediated by GLP-1.}},
url = {{http://dx.doi.org/10.1046/j.1464-5491.2002.00657_1.x}},
doi = {{10.1046/j.1464-5491.2002.00657_1.x}},
volume = {{19}},
year = {{2002}},
}